The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.

Say goodbye to the classic ClinicalTrials.gov!

The classic ClinicalTrials.gov website will be retired on June 25, 2024. Please use the modernized ClinicalTrials.gov. For more information, see ClinicalTrials.gov Modernization.

Key Record Dates

ClinicalTrials.gov Identifier:	NCT05029882
Brief Title:	Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab

First Submitted :	August 30, 2021
First Submitted that Met QC Criteria :	August 30, 2021
First Posted :	September 1, 2021

Last Update Submitted that Met QC Criteria :	April 10, 2024
Last Update Posted :	April 11, 2024

To Top